Generics Could Be Exceptional

We often read about the high cost of healthcare in this country. In fact, much of the world is faced with issues relating to rising healthcare costs. Perhaps the healthcare cost problems of other nations are not as acute as ours (because they spend less), but medical care costs are a global concern.

This is among the tailwinds propelling the generic drug market. When a proprietary drug comes off patent, generic makers step in and start selling lower-priced equivalents. But all is not perfect in this market. Competition is stiff, and after 2013, the value of patent expirations will decline. Of course, growth in the industry is heavily dependent on the expiration of patents of valuable drugs. That said, the generic drug market looks strong over the long term and should continue to perform well in the future....418 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.